Author:
Xiao Hao,Wen Yinxian,Pan Zhengqi,Shangguan Yangfan,Qin Jun,Tan Yang,Jiang Hongqiang,Li Bin,Zhang Qi,Chen Liaobin,Wang Hui
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference48 articles.
1. Vogel, J. P. et al. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health. Lancet 384, 1869–1877 (2014).
2. Porto, A. M., Coutinho, I. C., Correia, J. B. & Amorim, M. M. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial. BMJ 342, d1696 (2011).
3. Crowther, C. A., McKinlay, C. J., Middleton, P. & Harding, J. E. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst. Rev. 6, D3935 (2011).
4. Mori, R., Kusuda, S. & Fujimura, M. Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation. J. Pediatr. 159, 110–114 (2011).
5. Yinon, Y. et al. Should patients with documented fetal lung immaturity after 34 weeks of gestation be treated with steroids? Am. J. Obstet. Gynecol. 207, 221–222 (2012).
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献